Latest / Medical Device Global Market Access

US Market Access: How CMS Reimbursement Fueled the CGM and Insulin Pump Boom
This episode explores the rapid adoption of Continuous Glucose Monitors (CGMs) and insulin pumps in the United States, detailing how changes in reimbursement policy, specifically from the Centers for Medicare & Medicaid Services (CMS) in April 2023, transformed these devices from niche products to mainstream standards of care for a growing number of people with both type 1 and type 2 diabetes. - How did CGM technology transition from a niche to a mainstream medical device in the U.S.? - What critical role did CMS play in expanding market access for CGMs? - Why are more people with type 2…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.